secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001093557-23-000173
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q2 revenue $871.3M (+25% YoY), raises FY 2023 guidance
-------------------------------------------------------------

- Revenue $871.3M (+25% YoY); GAAP EPS $0.28, non-GAAP EPS $0.34.
- Raised FY 2023 revenue guidance to $3.50-3.55B (20-22% growth); Non-GAAP op margin ~17%.
- International revenue +38% reported (+40% organic); U.S. +21%.
- GAAP op margin 14.7% (+360 bps YoY); Non-GAAP op margin 18.2% (+360 bps).
- Initiated commercial production at Malaysia facility; completed $1.25B convertible notes offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000173/0001093557-23-000173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000173/dxcm-20230727.htm
  HTML page:      https://secwatch.observer/filing/0001093557-23-000173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer